Literature DB >> 26469120

The Basic Conservative Treatment of Temporomandibular Joint Anterior Disc Displacement Without Reduction--Review.

Marta Miernik1, Włodzimierz Więckiewicz1.   

Abstract

Temporomandibular joint derangement is a common disorder of the stomatognathic system. One type of these disorders is disc displacement without reduction with limited mouth opening, characterized by pain in affected TMJ and a decreased range of mouth opening. The natural course of closed lock is self-limiting. However, if there is no significant improvement after 12 weeks of following natural course of disc displacement without reduction, this is an indication that the therapy should be implemented. The article presents a review of the most commonly applied methods of basic conservative closed lock treatment. The most commonly applied methods of closed lock conservative management are: education and counseling, mandibular manipulation, splint therapy, exercise therapy and pharmacotherapy. The first choice method of treatment should be minimally invasive. The surgical management should be considered after unsuccessful conservative therapy. All presented methods of closed lock treatment seem to be effective in decreasing pain and reestablishing physiological range of motion.

Entities:  

Mesh:

Year:  2015        PMID: 26469120     DOI: 10.17219/acem/35165

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  9 in total

Review 1.  Tissue Engineering for the Temporomandibular Joint.

Authors:  Timothy M Acri; Kyungsup Shin; Dongrim Seol; Noah Z Laird; Ino Song; Sean M Geary; Jaidev L Chakka; James A Martin; Aliasger K Salem
Journal:  Adv Healthc Mater       Date:  2018-12-17       Impact factor: 9.933

2.  Association between sexual maturation and anterior disc displacement of temporomandibular joint in adolescents aged 13-14 years.

Authors:  Pei Shen; Dahe Zhang; Ahmed Abdelrehem; Shan Jin; Yi Luo; Chi Yang
Journal:  Clin Oral Investig       Date:  2022-09-14       Impact factor: 3.606

3.  Orthodontic management of anterior disc displacement without reduction.

Authors:  Fahad F Alsulaimani; Wafa A Alswajy
Journal:  J Orthod Sci       Date:  2022-05-04

4.  Clinical efficacy of a centric relation occlusal splint and intra-articular liquid phase concentrated growth factor injection for the treatment of temporomandibular disorders.

Authors:  Jung-Wu Yang; Yi-Chia Huang; Shang-Liang Wu; Shun-Yao Ko; Chiang-Chin Tsai
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

5.  A Prognostic Nomogram for Postoperative Bone Remodeling in Patients with ADDWoR.

Authors:  Xiaohan Liu; Pei Shen; Xiangyu Wang; Shanyong Zhang; Jiawei Zheng; Chi Yang
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

6.  Application of auriculotemporal nerve block and dextrose prolotherapy in exercise therapy of TMJ closed lock in adolescents and young adults.

Authors:  Hongzhi Zhou; Yang Xue; Ping Liu
Journal:  Head Face Med       Date:  2021-03-27       Impact factor: 2.151

7.  "RA.DI.CA." Splint for the Management of the Mandibular Functional Limitation: A Retrospective Study on Patients with Anterior Disc Displacement without Reduction.

Authors:  Carlo Di Paolo; Giovanni Falisi; Fabrizio Panti; Paola Di Giacomo; Alessandro Rampello
Journal:  Int J Environ Res Public Health       Date:  2020-12-04       Impact factor: 3.390

8.  The effect of functional mandibular advancement for adolescent patients with skeletal class II malocclusion on the TMJ: a systematic review and meta-analysis.

Authors:  Lan Ding; Rui Chen; Jiaxin Liu; Yuan Wang; Qian Chang; Liling Ren
Journal:  BMC Oral Health       Date:  2022-03-03       Impact factor: 2.757

9.  COL12A1 Single Nucleotide Polymorphisms rs240736 and rs970547 Are Not Associated with Temporomandibular Joint Disc Displacement without Reduction.

Authors:  Bartosz Dalewski; Katarzyna Kaczmarek; Anna Jakubowska; Kamila Szczuchniak; Łukasz Pałka; Ewa Sobolewska
Journal:  Genes (Basel)       Date:  2021-05-05       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.